These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10901501)

  • 1. The results of the GISSI-Prevenzione trial in the general framework of secondary prevention.
    Marchioli R; Valagussa F
    Eur Heart J; 2000 Jun; 21(12):949-52. PubMed ID: 10901501
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione].
    Marchioli R
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):745-6. PubMed ID: 12503535
    [No Abstract]   [Full Text] [Related]  

  • 3. GISSI-Prevenzione trial.
    Ng W; Tse HF; Lau CP
    Lancet; 1999 Oct; 354(9189):1555-6; author reply 1556-7. PubMed ID: 10551521
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
    Marchioli R; Marfisi RM; Borrelli G; Chieffo C; Franzosi MG; Levantesi G; Maggioni AP; Nicolosi GL; Scarano M; Silletta MG; Schweiger C; Tavazzi L; Tognoni G
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S34-7. PubMed ID: 17876196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GISSI-Prevenzione trial.
    Hopper L; Ness A; Higgins JP; Moore T; Ebrahim S
    Lancet; 1999 Oct; 354(9189):1557. PubMed ID: 10551523
    [No Abstract]   [Full Text] [Related]  

  • 6. GISSI-Prevenzione trial.
    Jialal I; Devaraj S; Huet BA; Traber M
    Lancet; 1999 Oct; 354(9189):1554; author reply 1556-7. PubMed ID: 10551518
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
    Marchioli R; Levantesi G; Macchia A; Marfisi RM; Nicolosi GL; Tavazzi L; Tognoni G; Valagussa F;
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):347-50. PubMed ID: 16645413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do fish oils or vitamin E reduce morbidity and mortality after myocardial infarction?
    Rand PJ; Schooff M
    J Fam Pract; 1999 Nov; 48(11):847-8. PubMed ID: 10907618
    [No Abstract]   [Full Text] [Related]  

  • 9. The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI)-Prevenzione Trial on fish oil and vitamin E supplementation in myocardial infarction survivors.
    Stone NJ
    Curr Cardiol Rep; 2000 Sep; 2(5):445-51. PubMed ID: 10980913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
    Verboom CN;
    Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.
    Marchioli R; Levantesi G; Macchia A; Maggioni AP; Marfisi RM; Silletta MG; Tavazzi L; Tognoni G; Valagussa F;
    J Membr Biol; 2005 Jul; 206(2):117-28. PubMed ID: 16456722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Marchioli R; Di Pasquale A
    G Ital Cardiol; 1993 Sep; 23(9):933-64. PubMed ID: 8119523
    [No Abstract]   [Full Text] [Related]  

  • 13. [Omega-3 polyunsaturated fatty acids and cardiovascular diseases].
    Marchioli R
    Minerva Cardioangiol; 2003 Oct; 51(5):561-76. PubMed ID: 14551524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GISSI-Prevenzione trial.
    Salen P; de Lorgeril M
    Lancet; 1999 Oct; 354(9189):1555; author reply 1556-7. PubMed ID: 10551520
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
    Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease.
    Shekelle PG; Morton SC; Jungvig LK; Udani J; Spar M; Tu W; J Suttorp M; Coulter I; Newberry SJ; Hardy M
    J Gen Intern Med; 2004 Apr; 19(4):380-9. PubMed ID: 15061748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
    Macchia A; Levantesi G; Franzosi MG; Geraci E; Maggioni AP; Marfisi R; Nicolosi GL; Schweiger C; Tavazzi L; Tognoni G; Valagussa F; Marchioli R;
    Eur J Heart Fail; 2005 Aug; 7(5):904-9. PubMed ID: 16087142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 polyunsatured fatty acids role in postmyocardial infarction therapy.
    Imazio M; Forno D; Quaglia C; Trinchero R
    Panminerva Med; 2003 Jun; 45(2):99-107. PubMed ID: 12855934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive use of N-3 fatty acids.
    Harris WS; O'Keefe JH
    Circulation; 2003 Nov; 108(19):e139; author reply e139. PubMed ID: 14610002
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter by Halcox regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction".
    Halcox JP
    Circulation; 2011 Jul; 124(1):e21; author reply e24-5. PubMed ID: 21730312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.